Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats

International Journal of Neuropsychopharmacology

Volumn 17, Issue 10, 2014, Pages 1695-1706

  Wallace, Ashley ^a   Pehrson, Alan L ^b   Sánchez, Connie ^b   Morilak, David A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b LUNDBECK RESEARCH USA   (United States)

Author keywords

Antidepressant; Chronic stress; Cognitive flexibility; Orbitofrontal cortex; Reversal learning; Serotonin

Indexed keywords

FENCLONINE; SEROTONIN; SEROTONIN RECEPTOR; VORTIOXETINE; ANXIOLYTIC AGENT; ENZYME INHIBITOR; PHENYLALANINE; PHENYLALANINE METHYL ESTER; PIPERAZINE DERIVATIVE; SULFIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD BRAIN BARRIER; CHRONIC INTERMITTENT COLD STRESS; CHRONIC STRESS; COLD STRESS; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG MECHANISM; HABITUATION; LEARNING DISORDER; MALE; NONHUMAN; ORBITAL CORTEX; PRIORITY JOURNAL; RAT; TISSUE HOMOGENATE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; ATTENTION; BODY WEIGHT; COLD; COMPLICATION; DEFICIENCY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ETIOLOGY; LEARNING; LEARNING DISORDERS; MENTAL STRESS; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ATTENTION; AUTORADIOGRAPHY; BODY WEIGHT; COLD TEMPERATURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; LEARNING DISORDERS; MALE; PHENYLALANINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; REVERSAL LEARNING; SEROTONIN; STRESS, PSYCHOLOGICAL; SULFIDES;

EID: 84930247852     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000571     Document Type: Article

References (63)

1. Alvarez E, Perez V, Dragheim M, Loft H, Artigas F (2012) A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. Int J Neuropsychopharmacol 15:589-600.
2. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF (2005) Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neurosci 8:365-371.
3. Areberg J, Luntang-Jensen M, Sogaard B, Nilausen DO (2012) Occupancy of the serotonin transporter after administration of Lu AA21004 and its relation to plasma concentration in healthy subjects. Basic Clin Pharmacol Toxicol 110:401-404.
4. Artigas F, Celada P, Laruelle M, Adell A (2001) How does pindolol improve antidepressant action? Trends Pharmacol Sci 22:224-228.
5. Austin M-P, Mitchell P, Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Brit J Psychiatry 178:200-206.
6. Bang-Anderson B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB (2011) Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem 54:3206-3221.
7. Beck AT (1976) Cognitive therapy and the emotional disorders. New York: International University Press.
8. Bétry C, Pehrson AL, Etiévant A, Ebert B, Sánchez C, Haddjeri N (2013) The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT3 receptor antagonism. Int J Neuropsychopharmacol 16:1115-1127.
9. Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320-4324.
10. Blier P, de Montigny C (1987) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1:470-480.
11. Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C (2007) Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 321:690-698.
12. Boulougouris V, Dalley JW, Robbins TW (2007) Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Beh Brain Res 179:219-228.
13. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
14. Chenu F, David DJP, Leroux-Nicollet I, Le Maître E, Gardier AM, Bourin M (2008) Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system. J Psychiatr Neurosci 33:541-550.
15. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC (2007) Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cerebral Cortex 17:18-27.
16. Coles ME, Heimberg RG (2002) Memory biases in the anxiety disorders: current status. Clin Psychol Rev 22:587-627.
17. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Revs 29:547-569.
18. Detke MJ, Wieland S, Lucki I (1995) Blockade of the antidepressant effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacol (Berl) 119:47-54.
19. Dias R, Robbins TW, Roberts AC (1996) Primate analogue of the Wisconsin Card Sorting Test: Effects of excitotoxic lesions of the prefrontal cortex of the marmoset. Behav Neurosci 110:872-886.
20. du Jardin KG, Jensen JB, Sánchez C, Pehrson AL (2014) Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5HT1A receptor agonism and 5-HT3 receptor antagonist. Eur Neuropsychopharmacol 24:160-171.
21. Eaves G, Rush AJ (1984) Cognitive patterns in symptomatic and remitted unipolar major depression. J Abnorm Psychol 93:31-40.
22. Fava M (2006) Pharmacological approaches to the treatment of residual symptoms. J Psychopharmacol 20:29-34.
23. FDA (Food and Drug Administration) (2013) Brintellix medication guide. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370633.pdf.
24. Fellows LK, Farah MJ (2003) Ventromedial frontal cortex mediates affective shifting in humans: evidence from reversal learning paradigm. Brain 126:1830-1837.
25. Fossati P, Amar G, Raoux N, Ergis AM, Allilaire JF (1999) Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia. Psychiatry Res 89:171-187.
26. Furr A, Lapiz-Bluhm DS, Morilak DA (2012) 5-HT2A-receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. Int J Neuropsychopharmacol 15:1295-1305.
27. Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ (2009) What did STAR∗D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 60:1439-1445.
28. Hampshire A, Owen AM (2006) Fractionating attentional control using event-related fMRI. Cereb Cortex 16: 1679-1689.
29. Hampshire A, Chaudhry AM, Owen AM, Roberts AC (2012) Dissociable roles for lateral orbitofrontal cortex and lateral prefrontal cortex during preference driven reversal learning. NeuroImage 59:4102-4112.
30. Hedlund PB, Sutcliffe JG (2004) Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 25:481-486.
31. Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Abarca J.E., Herrera-Guzmán D, Montelongo-Pedraza P, Blázquez FP, Peró-Cebollero M, Guàrdia-Olmos J (2010) Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. J Affective Disord 123:341-350.
32. Jaeger J, Berns S, Uzelac S, Davis-Conway S (2006) Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res 145:39-48.
33. Katona C, Hansen T, Olsen CK (2012) A randomized, doubleblind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27:215-223.
34. Kehagia AA, Murray GK, Robbins TW (2010) Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20:199-204.
35. Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156:837-841.
36. Kessler RC (1997) The effects of stressful life events on depression. Ann Rev Psychol 48:191-214.
37. Kreilgaard M, Smith DG, Brennum LT, Sanchez C (2008) Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol 155:276-284.
38. Lapiz MDS, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137:1039-1049.
39. Lapiz-Bluhm MDS, Morilak DA (2010) A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment. Int J Neuropsychopharmacol 13:997-1009.
40. Lapiz-Bluhm MDS, Soto-Piña AE, Hensler JG, Morilak DA (2009) Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacol 202:329-341.
41. Lucki I, Singh A, Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Revs 18:85-95.
42. Mathews A, Mackintosh B (1998) A cognitive model of selective processing in anxiety. Cognitive Ther Res 22:539-560.
43. McAlonan K, Brown VJ (2003) Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146:97-103.
44. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA (1999) Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry 156:780-782.
45. Meyer JH (2007) Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatr Neurosci 32:86-102.
46. Morales M, Battenberg E, de Lecea L, Bloom FE (1996) The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res 731:199-202.
47. Mørk A, Pehrson A, Brennum LT, Nielsen SM, Zhong H, Lassen AB, Miller S, Westrich L, Boyle NJ, Sánchez C, Fischer CW, Liebenberg N, Wegener G, Bundgaard C, Hogg S, Bang-Anderson B, Stensbøl TB (2012) Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther 340:666-675.
48. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999) Emotional bias and inhibitory control processes in mania and depression. Psychol Med 29:1307-1321.
49. Naismith SL, Longley WA, Scott EM, Hickie IB (2007) Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry 7:32.
50. Nikiforuk A (2012) Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Beh Brain Res 226:118-123.
51. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. San Diego: Academic Press.
52. Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.
53. Pehrson A, Cremers T, Bétry C, van der Hart MGC, Jørgensen L, Madsen M, Haddjeri N, Ebert B, Sánchez C (2013) Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters - a rat microdialysis and electrophysiology study. Eur Neuropsychopharmacol 23:133-145.
54. Piñeyro G, Blier P (1999) Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51:533-591.
55. Puig MV, Santana N, Celada P, Mengod G, Artigas F (2004) In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb Cortex 14:1365-1375.
56. Ramamoorthy R, Radhakrishnan M, Borah M (2008) Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models. Behav Pharmacol 19:29-40.
57. Rygula R, Walker S, Clarke H, Robbins TW, Roberts A (2010) Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 30:14552-14559.
58. Sarkisyan G, Roberts AJ, Hedlund PB (2010) The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior. Beh Brain Res 209:99-108.
59. Stenkrona P, Halldin C, Lundberg J (2013) 5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects. Eur Neuropsychopharmacol 23: 1190-1198.
60. Suwabe A, Kubota M, Niwa M, Kobayashi K, Kanba S (2000) Effect of a 5-HT1A receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats. Brain Res 858:393-401.
61. Suzuki M, Matsuda T, Asano S, Somboonthum P, Takuma K, Baba A (1995) Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation. Br J Pharmacol 115:703-711.
62. Tatarczynska E, Antkiewicz-Michaluk L, Klodzinska A, Stachowicz K, Chojnacka-Wojcik E (2005) Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action. Eur J Pharmacol 516:46-50.
63. Westrich L, Pehrson A, Zhong H, Nielsen SM, Frederiksen K, Stensbøl TB, Boyle N, Hentzer M, Sánchez C (2012) In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets. Int J Psychiatr Clin Pract 16 (Suppl. 1):47.